Veterinary Medicines

VITBPLEX Solution for Injection

Not authorised
  • Nicotinamide
  • Ascorbic acid
  • RIBOFLAVIN SODIUM PHOSPHATE
  • Thiamine hydrochloride
  • Pyridoxine hydrochloride
Download as PDF

Product identification

Medicine name:
VITBPLEX Solution for Injection
Active substance:
  • Nicotinamide
  • Ascorbic acid
  • RIBOFLAVIN SODIUM PHOSPHATE
  • Thiamine hydrochloride
  • Pyridoxine hydrochloride
Target species:
  • Cattle
  • Sheep
  • Pig
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Nicotinamide
    23.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Ascorbic acid
    70.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • RIBOFLAVIN SODIUM PHOSPHATE
    0.50
    milligram(s)
    /
    1.00
    millilitre(s)
  • Thiamine hydrochloride
    35.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Pyridoxine hydrochloride
    7.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11E
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Ireland
Package description:
  • The veterinary medicinal product is packaged in a 100 ml amber Type II glass vial, sealed with bromobutyl bung and aluminium cap.
  • The veterinary medicinal product is packaged in a 50 ml amber Type II glass vial, sealed with bromobutyl bung and aluminium cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chem-Pharm
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
Responsible authority:
  • HPRA
Authorisation number:
  • VPA10823/018/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download